Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 1997
Association of a polymorphism in the dopamine-transporter gene with Parkinson's diseaseD G Le Couteur, P W Leighton, S J McCann, et al.
Journal of the Neurological Sciences|February 10, 1998
The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysisS J McCann, S M Pond, K M James, et al.
Clinical Pharmacology and Therapeutics|February 1, 1982
Lack of effect of diazepam on methadone metabolism in methadone-maintained addictsS M Pond, T G Tong, N L Benowitz, et al.
International Journal of Immunopharmacology|January 1, 1988
Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragmentsM Bowles, S C Johnston, D D Schoof, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1988
Clinical applicability of current pharmacokinetic models: splanchnic elimination of 5-fluorouracil in cancer patientsP J Robinson, L Bass, S M Pond, et al.
Journal of Clinical Psychopharmacology|October 1, 1992
Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophreniaH A Whiteford, T J Stedman, J Welham, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1982
A technique to study hepatic and intestinal drug metabolism separately in the dogD J Effeney, S M Pond, M W Lo, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
Altered methadone pharmacokinetics in methadone-maintained pregnant womenS M Pond, M J Kreek, T G Tong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
Pharmacokinetics and toxicity of high doses of antibody Fab fragments in ratsP R Pentel, D E Keyler, D G Gilbertson, et al.
Pageof 21